|
Mortality |
Mortality |
|
All-cause |
Respiratory disease-related |
|
HR (95% CI) |
HR (95% CI) |
COPD |
|
|
Control cohort |
Ref |
Ref |
Asthma cohort without COPD |
0.95 (0.90–1.01) |
1.58
(1.32–1.89) |
Asthma cohort with COPD |
1.49 (1.39–1.59) |
4.27
(3.66–4.99) |
Bronchiectasis |
|
|
Control cohort |
Ref |
Ref |
Asthma cohort without bronchiectasis |
1.12 (1.06–1.17) |
2.38
(2.08–2.72) |
Asthma cohort with bronchiectasis |
1.43 (1.18–1.73) |
6.35
(4.59–8.78) |
Lung cancer |
|
|
Control cohort |
Ref |
Ref |
Asthma cohort without lung cancer |
1.12 (1.07–1.18) |
2.55
(2.24–2.90) |
Asthma cohort with lung cancer |
4.11 (2.59–6.52) |
13.25
(0.46–23.09) |
Pneumonia |
|
|
Control cohort |
Ref |
Ref |
Asthma cohort without pneumonia |
1.03 (0.98–1.09) |
2.08
(1.79–2.41) |
Asthma cohort with pneumonia |
1.59 (1.46–1.74) |
4.72
(3.89–5.73) |
NTM infection |
|
|
Control cohort |
Ref |
Ref |
Asthma cohort without NTM infection |
1.13 (1.08–1.18) |
2.54
(2.23–2.89) |
Asthma cohort with NTM infection |
0.85 (0.12–6.00) |
8.45
(1.19–60.21) |